NCT00004815|Completed
Loading search results
Sponsor study identifier
Secondary identifiers
interventional
1
0 countries
N/A
Study Start
May 1992
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
Not reported
Date not reportedOBJECTIVES: I. Assess the safety and efficacy of recombinant human insulin-like growth factor 1 in a patient with Werner's syndrome and osteoporosis.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 1992
Date type not reportedThis date has not been verified as actual or estimated.
February 24, 2000
Actual (reported)February 25, 2000
Actual (reported)Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Craig D. Rubin
University of Texas
First Submitted
February 24, 2000
First Posted
February 25, 2000
Study Start
May 1992
Date type not reportedThis date has not been verified as actual or estimated.
Last Updated
June 24, 2005
Record last verified: 2004-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
The Effect of Local Injectet GH on the Collagen Synthesis in the Ligamentum Patella